Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults
Completed · Phase 2
Conditions studied: Gastroenteritis
In brief
The purpose of this trial is to obtain serum for proficiency testing to confirm assay validity is maintained following the dosing of adults with a pediatric dose of HIL-214.
Key facts
- Study ID
- NCT05972733
- Run by
- HilleVax
- People needed
- 80
- Starts
- 2023-08-01
- Expected to finish
- 2023-11-10
- Last updated by the study team
- 2025-08-19
Who can join
Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female subjects aged 18 to 49 years, inclusive.
- Individuals who are in good health at the time of entry into the trial as determined by medical history, physical examination (including vital signs) and clinical judgment of the investigator.
- The individual signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any trial procedures, after the nature of the trial has been explained according to regulatory requirements.
- Individuals willing and able to comply with trial procedures and are available for the duration of follow-up.
You may not qualify if…
- Females who are pregnant or breastfeeding.
- Gastroenteritis within 14 days before planned dosing (can warrant delay of trial vaccine administration).
- Known hypersensitivity or allergy to any of the HIL-214 components (including excipients).
- Known or suspected impairment/alteration of immune function, including history of any autoimmune disease or neuro-inflammatory disease.
- Any serious chronic or progressive disease (including hepatitis B or C).
- Previous exposure to an experimental norovirus vaccine.
- Subject or subject's first-degree relatives are involved in the trial conduct.
Where it is running
- Pennisula Research Associates — Rolling Hills Estates, California, United States
- Clinical Research Atlanta — Stockbridge, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.